1. Home
  2. ARQ vs MOLN Comparison

ARQ vs MOLN Comparison

Compare ARQ & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQ
  • MOLN
  • Stock Information
  • Founded
  • ARQ 1996
  • MOLN 2004
  • Country
  • ARQ United States
  • MOLN Switzerland
  • Employees
  • ARQ N/A
  • MOLN N/A
  • Industry
  • ARQ
  • MOLN
  • Sector
  • ARQ
  • MOLN
  • Exchange
  • ARQ NYSE
  • MOLN Nasdaq
  • Market Cap
  • ARQ 175.6M
  • MOLN 183.2M
  • IPO Year
  • ARQ N/A
  • MOLN 2021
  • Fundamental
  • Price
  • ARQ $4.16
  • MOLN $3.84
  • Analyst Decision
  • ARQ Strong Buy
  • MOLN
  • Analyst Count
  • ARQ 1
  • MOLN 0
  • Target Price
  • ARQ $9.00
  • MOLN N/A
  • AVG Volume (30 Days)
  • ARQ 329.3K
  • MOLN 4.8K
  • Earning Date
  • ARQ 03-05-2025
  • MOLN 03-06-2025
  • Dividend Yield
  • ARQ N/A
  • MOLN N/A
  • EPS Growth
  • ARQ N/A
  • MOLN N/A
  • EPS
  • ARQ N/A
  • MOLN N/A
  • Revenue
  • ARQ $108,959,000.00
  • MOLN $5,484,562.00
  • Revenue This Year
  • ARQ $32.45
  • MOLN N/A
  • Revenue Next Year
  • ARQ $16.18
  • MOLN $528.57
  • P/E Ratio
  • ARQ N/A
  • MOLN N/A
  • Revenue Growth
  • ARQ 9.86
  • MOLN N/A
  • 52 Week Low
  • ARQ $4.01
  • MOLN $3.32
  • 52 Week High
  • ARQ $8.26
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • ARQ 27.49
  • MOLN 42.45
  • Support Level
  • ARQ $4.04
  • MOLN $3.88
  • Resistance Level
  • ARQ $4.70
  • MOLN $4.56
  • Average True Range (ATR)
  • ARQ 0.22
  • MOLN 0.27
  • MACD
  • ARQ -0.02
  • MOLN 0.01
  • Stochastic Oscillator
  • ARQ 14.95
  • MOLN 25.69

About ARQ ARQ INC

Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: